Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Miriam, Scarpa"'
Autor:
Igor C. Fontana, Miriam Scarpa, Mona-Lisa Malarte, Filipa M. Rocha, Sira Ausellé-Bosch, Marina Bluma, Marco Bucci, Konstantinos Chiotis, Amit Kumar, Agneta Nordberg
Publikováno v:
Cells, Vol 12, Iss 11, p 1469 (2023)
Reactive astrogliosis is an early event in the continuum of Alzheimer’s disease (AD). Current advances in positron emission tomography (PET) imaging provide ways of assessing reactive astrogliosis in the living brain. In this review, we revisit cli
Externí odkaz:
https://doaj.org/article/96390f2111d248a19a348c57b2550c76
Autor:
Louis, Dwomoh, Mario, Rossi, Miriam, Scarpa, Elham, Khajehali, Colin, Molloy, Pawel, Herzyk, Shailesh N, Mistry, Andrew R, Bottrill, Patrick M, Sexton, Arthur, Christopoulos, Jeffrey, Conn, Craig W, Lindsley, Sophie J, Bradley, Andrew B, Tobin
Publikováno v:
Science signaling. 15(760)
Many dementias are propagated through the spread of "prion-like" misfolded proteins. This includes prion diseases themselves (such as Creutzfeldt-Jakob disease) and Alzheimer's disease (AD), for which no treatments are available to slow or stop progr
Autor:
Louis Dwomoh, Mario Rossi, Miriam Scarpa, Elham Khajehali, Colin Molloy, Pawel Herzyk, Shailesh N. Mistry, Andrew R. Bottrill, Patrick M. Sexton, Arthur Christopoulos, Jeffrey Conn, Craig W. Lindsley, Sophie J. Bradley, Andrew B. Tobin
Publikováno v:
Science Signaling. 15
Many dementias are propagated through the spread of “prion-like” misfolded proteins. This includes prion diseases themselves (such as Creutzfeldt-Jakob disease) and Alzheimer’s disease (AD), for which no treatments are available to slow or stop
Autor:
Sophie J. Bradley, Shailesh N. Mistry, Patrick M. Sexton, Elham Khajehali, Colin Molloy, Miriam Scarpa, Andrew R. Bottrill, P. Jeffery Conn, Pawel Herzyk, Mario Rossi, Arthur Christopoulos, Craig W. Lindsley, Louis Dwomoh, Andrew B. Tobin
The most prevalent types of dementias, including Alzheimer’s disease, are those that are propagated via the spread of “prion-like” misfolded proteins. Despite considerable effort no treatments are available to slow or stop the progression of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68ffd93afdb37e9547c32a948682b7d5
https://doi.org/10.1101/2021.07.30.454298
https://doi.org/10.1101/2021.07.30.454298
Publikováno v:
PROLÍNGUA. 14:79-93
This paper aims to analyze which strategy speakers of English as L1 and Brazilian speakers of English as L2 use to solve stress clash, a phenomenon in which two syllables bearing primary stress are adjacent in different words forming a phonological p
Autor:
Sophie J. Bradley, Andrew B. Tobin, Colin Molloy, Brian D. Hudson, Gonzalo S. Tejeda, Sara Marsango, Louis Dwomoh, Graeme Milligan, Zeshan Ahmed, Miriam Scarpa, Mario Rossi, Laura Jenkins
There are currently no treatments that can slow the progression of neurodegenerative diseases such as Alzheimer’s disease (AD). There is, however, a growing body of evidence that activation of the M1 muscarinic acetylcholine receptor (M1-receptor)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c6e71655535532b01e569eae3877854
https://doi.org/10.1101/2021.04.29.440753
https://doi.org/10.1101/2021.04.29.440753
Publikováno v:
Advances in pharmacology (San Diego, Calif.). 88
The M1 muscarinic acetylcholine receptor (mAChR) plays a crucial role in learning and memory processes and has long been identified as a promising therapeutic target for the improvement of cognitive decline in Alzheimer's disease (AD). As such, clini
Autor:
Mario Rossi, R. A. John Challiss, Colin Molloy, Eyassu Chernet, Sophie J. Bradley, Paulina Valuskova, Lisa M. Broad, Adrian J. Mogg, Karolina Gherbi, Vanessa N. Barth, Elizabeth M. Rosethorne, Andrew B. Tobin, Arthur Christopoulos, Caroline A. Wilson, Lisa Finlayson, Louis Dwomoh, Miriam Scarpa, Rajendra Mistry, Shuzo Sakata, Patrick M. Sexton, Kjell A. Svensson, David A. Sykes
Cholinesterase inhibitors, the current frontline symptomatic treatment for Alzheimer’s disease (AD), are associated with low efficacy and adverse effects. M1 muscarinic acetylcholine receptors (M1 mAChRs) represent a potential alternate therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e98a59cb796f11c7703f6b34d2e88b3
https://strathprints.strath.ac.uk/71527/1/Bradley_etal_NCB_2019_Biased_M1_muscarinic_receptor_mutant_mice_inform.pdf
https://strathprints.strath.ac.uk/71527/1/Bradley_etal_NCB_2019_Biased_M1_muscarinic_receptor_mutant_mice_inform.pdf
The M1 muscarinic acetylcholine receptor (mAChR) plays a crucial role in learning and memory processes and has long been identified as a promising therapeutic target for the improvement of cognitive decline in Alzheimer's disease (AD). As such, clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc0f62c643e3a120486b2355bd8544ba
https://doi.org/10.1016/bs.apha.2019.12.003
https://doi.org/10.1016/bs.apha.2019.12.003
Autor:
Ester Miriam Scarpa
Publikováno v:
Alfa: Revista de Lingüística, Vol 44, Iss 0 (2001)
Os distúrbios prosódicos da afasia e disartria, na literatura daárea, têm sido vinculados à questão da lateralização da lesão e, conseqüentemente,do processamento lingüístico: a prosódia "lingüística" seria processadano hemisfério esq
Externí odkaz:
https://doaj.org/article/f5710d2f3f10478c9c78b5f4aed1d46a